Cellular HIV-1 inhibition by truncated old world primate APOBEC3A proteins lacking a complete deaminase domain

Virology. 2014 Nov:468-470:532-544. doi: 10.1016/j.virol.2014.09.001. Epub 2014 Sep 28.

Abstract

The APOBEC3 (A3) deaminases are retrovirus restriction factors that were proposed as inhibitory components of HIV-1 gene therapy vectors. However, A3 mutational activity may induce undesired genomic damage and enable HIV-1 to evade drugs and immune responses. Here, we show that A3A protein from Colobus guereza (colA3A) can restrict HIV-1 replication in producer cells in a deaminase-independent manner without inducing DNA damage. Neither HIV-1 reverse transcription nor integration were significantly affected by colA3A, but capsid protein synthesis was inhibited. The determinants for colA3A restriction mapped to the N-terminal region. These properties extend to A3A from mandrills and De Brazza's monkeys. Surprisingly, truncated colA3A proteins expressing only the N-terminal 100 amino acids effectively exclude critical catalytic regions but retained potent cellular restriction activity. These highlight a unique mechanism of cellular HIV-1 restriction by several Old World monkey A3A proteins that may be exploited for functional HIV-1 cure strategies.

Keywords: APOBEC3A; DNA damage; Deaminase domain; HIV-1; Restriction factor; Structure–function.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Cell Line
  • Colobus*
  • Cytidine Deaminase / genetics
  • Cytidine Deaminase / metabolism*
  • Friend murine leukemia virus / physiology
  • Gene Expression Regulation, Enzymologic
  • HIV-1 / genetics*
  • HIV-1 / physiology*
  • Humans
  • Mutation
  • Protein Structure, Tertiary
  • Recombinant Proteins
  • Virus Replication / physiology*

Substances

  • Recombinant Proteins
  • Cytidine Deaminase